Clinical trial
First-in-Human Pilot Study of Epicardial Circular RNA-HM2002 Injection in CABG for Ischemic Heart Failure
NCT06621576
Study timeline
Study start (actual)2024-09-18Date precision: day
Registry last updated2026-05-08
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Ischaemic Heart Diseaseunresolved
Heart Failureunresolved
Interventions
HM2002 injectionDRUG
Sponsors & collaborators
Ruijin Hospitallead sponsor
Shanghai CirCode Biomed Co.,Ltdcollaborator
Shanghai Bestudy Medical Technology Co., Ltdcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06621576 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.